BR9709792A - Utilização de antagonistas h2 para a fabricação de uma composição tópica para o tratamento de resfriados - Google Patents

Utilização de antagonistas h2 para a fabricação de uma composição tópica para o tratamento de resfriados

Info

Publication number
BR9709792A
BR9709792A BR9709792A BR9709792A BR9709792A BR 9709792 A BR9709792 A BR 9709792A BR 9709792 A BR9709792 A BR 9709792A BR 9709792 A BR9709792 A BR 9709792A BR 9709792 A BR9709792 A BR 9709792A
Authority
BR
Brazil
Prior art keywords
colds
antagonists
manufacture
treatment
topical composition
Prior art date
Application number
BR9709792A
Other languages
English (en)
Inventor
Robert Ernest Singer Jr
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9709792A publication Critical patent/BR9709792A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9709792A 1996-06-12 1997-06-10 Utilização de antagonistas h2 para a fabricação de uma composição tópica para o tratamento de resfriados BR9709792A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66238996A 1996-06-12 1996-06-12
PCT/US1997/009977 WO1997047292A1 (en) 1996-06-12 1997-06-10 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds

Publications (1)

Publication Number Publication Date
BR9709792A true BR9709792A (pt) 1999-08-10

Family

ID=24657514

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709792A BR9709792A (pt) 1996-06-12 1997-06-10 Utilização de antagonistas h2 para a fabricação de uma composição tópica para o tratamento de resfriados

Country Status (8)

Country Link
EP (1) EP0954294A1 (pt)
JP (1) JPH11513035A (pt)
CN (1) CN1221338A (pt)
AU (1) AU3306997A (pt)
BR (1) BR9709792A (pt)
CA (1) CA2257990A1 (pt)
ID (1) ID19099A (pt)
WO (1) WO1997047292A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
AU2001242313A1 (en) * 2000-03-21 2001-10-15 Astion Development Aps Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist
MXPA03000043A (es) * 2000-06-30 2003-10-15 Procter & Gamble Promocion de la salud en todo el cuerpo.
JP2004517038A (ja) * 2000-06-30 2004-06-10 ザ、プロクター、エンド、ギャンブル、カンパニー 全身の健康増進
JP2003321366A (ja) * 2002-04-30 2003-11-11 Ucb Japan Kk 炎症性腸疾患の予防または治療剤
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
JPH06506198A (ja) * 1991-03-04 1994-07-14 ワーナー−ランバート・コンパニー 種々な剤形の非ステロイド性抗炎症剤の新規な塩／イオン対
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis

Also Published As

Publication number Publication date
CN1221338A (zh) 1999-06-30
WO1997047292A1 (en) 1997-12-18
CA2257990A1 (en) 1997-12-18
ID19099A (id) 1998-06-11
JPH11513035A (ja) 1999-11-09
EP0954294A1 (en) 1999-11-10
AU3306997A (en) 1998-01-07

Similar Documents

Publication Publication Date Title
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
HUP0104676A3 (en) Compositions for the treatment of anorectal disorders and their use
BR9711530A (pt) Combina-Æo de terapia para tratamento de psicoses
NO20005913L (no) Legemiddelsammensetning
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
HUP0103621A3 (en) Fentanyl composition for the treatment of acute pain
FI950797L (fi) Antiperspiranttinen deodoranttikoostumus
FI950798A7 (fi) Antiperspiranttinen deodoranttikoostumus
FI950799A7 (fi) Antiperspiranttinen deodoranttikoostumus
PT1206436E (pt) Retinoides para o tratamento de enfisema
DE69700310D1 (de) Rostschutzzusammensetzung
DK1023035T3 (da) Mundplejemiddel
BR9706908A (pt) Composiçães para o tratamento de insuficiéncia renal compreendendo l-carnosina
BR9707078A (pt) Composição de sabão para o corpo
PT983275E (pt) Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes
PT1014927E (pt) Utilizacao de shogaois e de gingerois para a preparacao de composicoes desodorizantes
GB9816234D0 (en) Compounds for use in the treatment of inflammation
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
BR9709792A (pt) Utilização de antagonistas h2 para a fabricação de uma composição tópica para o tratamento de resfriados
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
PT928183E (pt) Utilizacao de 1-hidroxilo-2-piridoneno para o tratamento da dermatite seborroica
HUP0003803A3 (en) Use of flunarizine for producing pharmaceutical compositions useful for the topical treating of glaucoma
FR2780886B1 (fr) Composition auto-hydratante pour la peau

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal